BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7013793)

  • 1. Characterization of a kirromycin-resistant elongation factor Tu from Escherichia coli.
    Ivell R; Fasano O; Crechet JB; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1355-61. PubMed ID: 7013793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
    Fasano O; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
    Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
    EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutant elongation factor Tu which does not immobilize the ribosome upon binding of kirromycin.
    Duisterwinkel FJ; De Graaf JM; Schretlen PJ; Kraal B; Bosch L
    Eur J Biochem; 1981 Jun; 117(1):7-12. PubMed ID: 7021158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes.
    Fischer E; Wolf H; Hantke K; Parmeggiani A
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4341-5. PubMed ID: 337296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
    Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
    Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant ribosomes can generate dominant kirromycin resistance.
    Tubulekas I; Buckingham RH; Hughes D
    J Bacteriol; 1991 Jun; 173(12):3635-43. PubMed ID: 2050625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of elongation factor Tu with the ribosome. A study using the antibiotic kirromycin.
    Sander G; Ivell R; Crechet JB; Parmeggiani A
    Biochemistry; 1980 Mar; 19(5):865-70. PubMed ID: 6101963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular properties of two mutant species of the elongation factor Tu.
    Van der Meide PH; Duisterwinkel FJ; De Graaf JM; Kraal B; Bosch L; Douglass J; Blumenthal T
    Eur J Biochem; 1981 Jun; 117(1):1-6. PubMed ID: 7021152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.
    Landini P; Bandera M; Goldstein BP; Ripamonti F; Soffientini A; Islam K; Denaro M
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):649-52. PubMed ID: 1590753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoacyl-tRNA-elongation factor Tu-ribosome interaction leading to hydrolysis of guanosine 5'-triphosphate.
    Takahashi K; Ghag S; Chládek S
    Biochemistry; 1986 Dec; 25(25):8330-6. PubMed ID: 3545292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome.
    Tubulekas I; Hughes D
    J Bacteriol; 1993 Jan; 175(1):240-50. PubMed ID: 8416899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB.
    Van der Meide PH; Borman TH; Van Kimmenade AM; Van de Putte P; Bosch L
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3922-6. PubMed ID: 7001448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of the overproduced elongation factor Tu from Thermus thermophilus in protein biosynthesis of Escherichia coli.
    Zeidler W; Kreutzer R; Sprinzl M
    FEBS Lett; 1993 Mar; 319(1-2):185-8. PubMed ID: 8454054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function relationships of elongation factor Tu. Isolation and activity of the guanine-nucleotide-binding domain.
    Jensen M; Cool RH; Mortensen KK; Clark BF; Parmeggiani A
    Eur J Biochem; 1989 Jun; 182(2):247-55. PubMed ID: 2661226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
    Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
    J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.
    Hall CC; Watkins JD; Georgopapadakou NH
    Antimicrob Agents Chemother; 1989 Mar; 33(3):322-5. PubMed ID: 2499247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome.
    Zuurmond AM; Olsthoorn-Tieleman LN; Martien de Graaf J; Parmeggiani A; Kraal B
    J Mol Biol; 1999 Dec; 294(3):627-37. PubMed ID: 10610785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kirromycin-resistant EF-Tu species reverses streptomycin dependence of Escherichia coli strains mutated in ribosomal protein S12.
    Zuurmond AM; Zeef LAH; Kraal B
    Microbiology (Reading); 1998 Dec; 144 ( Pt 12)():3309-3316. PubMed ID: 9884222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.